Digital health coaching firm Liva Healthcare has secured a €24.4m funding package with the aim of strengthening its position in the chronic disease prevention market.
Headquartered in Copenhagen and London, the company provides human coaching programmes to help people manage obesity, pre-diabetes, type 2 diabetes and cardiovascular diseases, delivered through an app.
The funding round was led by Verlinvest. Also taking part in the round was all of Liva’s current main investors, MIG, Digital Health Ventures and Santo Venture Capital.
The round will enable Liva to enlarge its European footprint and operations.
CEO André Sode said: “This new funding, from one of Europe’s strongest purpose-led, consumer growth investors, will substantially accelerate our expansion in core European markets.
“COVID-19 has demonstrated how effective remote digital health solutions can be. With healthcare providers around the world looking for scalable solutions to combat the rise in diabetes and obesity, we are ideally placed to support and have experienced a significant increase in interest as a result.”
Simone Sallustio, executive director at Verlinvest, added: “This investment represents a major new entry into digital health for Verlinvest, where technology is fuelling consumer revolutions.
“Digital healthcare has been vital in getting treatment to patients during the pandemic and this trend will continue as effective virtual programmes give people more flexible healthcare options.
“Liva’s advanced technology and proven clinical outcomes set it apart from its competitors. In this exciting and rapidly evolving space, Liva’s experience and established partnerships represent a strategic choice for Verlinvest.”
Liva is used by clients such as Novo Nordisk, AXA Health, Amgen, City of Copenhagen, and Bupa Australia. The company is also a partner to NHS England on its National Diabetes Prevention Programme.
Sign up to our newsletter